HIPGEN | Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial
01-01-2018
-30-09-2022
01-01-2018
-30-09-2022
01-11-2021
-31-10-2025
01-09-2024
-31-08-2028
01-03-2016
-31-08-2019